Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints (Q5348691): Difference between revisions
From MaRDI portal
Created claim: Wikidata QID (P12): Q38927246, #quickstatements; #temporary_batch_1711574657256 |
ReferenceBot (talk | contribs) Changed an Item |
||
| Property / cites work | |||
| Property / cites work: The frailty model. / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Q4741623 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Sample-Size Formula for the Proportional-Hazards Regression Model / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: The asymptotic theory of permutation statistics. / rank | |||
Normal rank | |||
Latest revision as of 07:34, 14 July 2024
scientific article; zbMATH DE number 6762403
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints |
scientific article; zbMATH DE number 6762403 |
Statements
Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints (English)
0 references
18 August 2017
0 references
biomarkers
0 references
Cox proportional hazards model
0 references
log-rank test
0 references
sample size
0 references
shared frailty model
0 references
trial design
0 references
